Current Edition

Contract manufacturer Pfizer CentreOne expands fill-finish services to its Kalamazoo, Michigan, facility

Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, has expanded its fill-finish services to its Kalamazoo, Michigan, United States, site. Along with vial-filling of small molecules and biologics, the facility also provides vial-filling of sterile suspensions, expanding Pfizer CentreOne’s service portfolio.
Services at the Kalamazoo site encompass:

  • Small molecules and biologics
  • Sterile suspensions
  • Potent and controlled substances
  • Aqueous and oil-based formulations
  • Lyophilization
  • Vials 1-100mL; bulk formulation <1-1,600L

Technical transfer
The Kalamazoo facility has dedicated, onsite technical, manufacturing science, regulatory affairs and quality teams. Over the last five years, they’ve successfully transferred 37 customer and Pfizer compounds into the facility. Among Kalamazoo’s extensive scientific resources are experts in API processes who know how to solve complex issues with active ingredients; and a team of commodities experts who trouble-shoot problems with stoppers, glass and excipients.